Cargando…
A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
PURPOSE: When combined with chemotherapy, bevacizumab improves progression-free survival (PFS) in metastatic colorectal cancer (mCRC). This observational trial was designed to assess the safety and efficacy of bevacizumab plus first-line chemotherapy in a real-world setting in Lebanon. PATIENTS AND...
Autores principales: | Temraz, Sally, Nasr, Fadi, Kattan, Joseph, Abigerges, Dany, Moukadem, Walid, Farhat, Fadi, Maatouk, Layal, Chahine, Georges, Shamseddine, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881008/ https://www.ncbi.nlm.nih.gov/pubmed/35221671 http://dx.doi.org/10.2147/BTT.S340525 |
Ejemplares similares
-
Consensus on the management of platinum-sensitive high-grade serous epithelial ovarian cancer in Lebanon
por: Abdallah, Reem, et al.
Publicado: (2023) -
Prevalence of Her2-neu status and its clinicopathological association in newly diagnosed gastric cancer patients
por: Kattan, Joseph, et al.
Publicado: (2022) -
Overview in Breast Cancer Screening in Lebanon
por: Sbaity, Eman, et al.
Publicado: (2021) -
Trends in lung cancer incidence in Lebanon by gender and histological type over the period 2005–2008
por: Temraz, Sally, et al.
Publicado: (2017) -
Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019
por: Touma, Elsie, et al.
Publicado: (2021)